These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26725321)

  • 21. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.
    Kandhi R; Bobbala D; Yeganeh M; Mayhue M; Menendez A; Ilangumaran S
    Cytokine; 2016 Jun; 82():58-69. PubMed ID: 26748724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
    Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
    Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
    Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.
    Zhang Y; Liu Y; Duan J; Yan H; Zhang J; Zhang H; Fan Q; Luo F; Yan G; Qiao K; Liu J
    Hepatology; 2016 Mar; 63(3):880-97. PubMed ID: 26659654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
    Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
    Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
    Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-155 accelerates proliferation of mouse hepatocytes during liver regeneration by directly targeting SOCS1.
    Lin X; Chen L; Li H; Liu Y; Guan Y; Li X; Jia Z; Lin X; Jia J; Sun Y; Xiao D
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G443-G453. PubMed ID: 29792529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.
    Park JS; Qiao L; Gilfor D; Yang MY; Hylemon PB; Benz C; Darlington G; Firestone G; Fisher PB; Dent P
    Mol Biol Cell; 2000 Sep; 11(9):2915-32. PubMed ID: 10982390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
    Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
    Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.
    Gui Y; Yeganeh M; Cepero-Donates Y; Ramanathan S; Saucier C; Ilangumaran S
    Curr Pharm Des; 2014; 20(17):2922-33. PubMed ID: 23944359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
    Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
    Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asiatic acid promotes p21(WAF1/CIP1) protein stability through attenuation of NDR1/2 dependent phosphorylation of p21(WAF1/ CIP1) in HepG2 human hepatoma cells.
    Chen JY; Chen JY; Xu QW; Xu H; Huang ZH
    Asian Pac J Cancer Prev; 2014; 15(2):963-7. PubMed ID: 24568526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.
    Ohkoshi S; Yano M; Matsuda Y
    World J Gastroenterol; 2015 Nov; 21(42):12150-6. PubMed ID: 26576099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decorin deficiency promotes hepatic carcinogenesis.
    Horváth Z; Kovalszky I; Fullár A; Kiss K; Schaff Z; Iozzo RV; Baghy K
    Matrix Biol; 2014 Apr; 35():194-205. PubMed ID: 24361483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress.
    Yu X; Lv J; Zhu Y; Duan L; Ma L
    PLoS One; 2013; 8(1):e54265. PubMed ID: 23349842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
    Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
    Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.